Mai Brigsted Gregersen

Mai Brigsted Gregersen has a diverse and extensive work experience in the pharmaceutical and healthcare industry. Since 2007, they have held various roles in different companies.

Starting in 2007, Mai worked as a Drug Safety Officer at Boehringer Ingelheim in Singapore. Mai Brigsted then joined Nomeco in 2009, where they initially served as a Clinical Trial Specialist and later became a Teamleader for Clinical Trial Service.

In 2011, Mai joined Novo Nordisk A/S as an International Trial Manager, overseeing trials until 2013. Mai Brigsted then moved to Apotek 1 in 2013, where they served as a Pharmacy Manager for a year.

In 2014, Mai joined LEO Pharma A/S and held two roles: Senior Manager for Pre-clinical and Clinical Quality, as well as Head of Clinical & Regulatory Quality. Mai Brigsted stayed with LEO Pharma until 2016.

From 2016 to 2019, Mai worked at The Danish Medicines Agency as a GCP Inspector, ensuring compliance with Good Clinical Practice regulations. Mai Brigsted then returned to Novo Nordisk in 2019 as a Principal GCP Advisor Specialist until 2021.

In 2021, Mai joined Larix, a full-service Clinical CRO, as a Principal QA Specialist for a year. Following this, they moved to Novo Nordisk as a Quality and Compliance Officer for five months in 2022.

Mai Brigsted'smost recent position is as a QA GCP Senior Specialist at Bavarian Nordic, where they started in 2023 and is currently employed.

Throughout their career, Mai Brigsted Gregersen has gained significant expertise in quality assurance, compliance, and clinical trials, demonstrating their commitment and dedication to the industry.

Mai Brigsted Gregersen completed their M.Sc. in Pharmacy from Danmarks Farmaceutiske Universitet between 2000 and 2006.